|
SSB expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.371800E-04 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.315960E-03 |
| Normal-vs-Stage2 |
4.965800E-02 |
| Normal-vs-Stage3 |
6.37549999999987E-05 |
| Normal-vs-Stage4 |
1.797140E-03 |
| Stage1-vs-Stage2 |
8.897600E-01 |
| Stage1-vs-Stage3 |
1.094390E-01 |
| Stage1-vs-Stage4 |
7.528200E-01 |
| Stage2-vs-Stage3 |
5.073800E-01 |
| Stage2-vs-Stage4 |
9.669400E-01 |
| Stage3-vs-Stage4 |
3.210400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.643400E-04 |
| Normal-vs-AfricanAmerican |
1.499760E-02 |
| Normal-vs-Asian |
1.243600E-01 |
| Caucasian-vs-AfricanAmerican |
6.986200E-01 |
| Caucasian-vs-Asian |
9.340800E-01 |
| AfricanAmerican-vs-Asian |
8.086200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.01570000000406E-05 |
| Normal-vs-Female |
2.478400E-02 |
| Male-vs-Female |
9.476100E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.136200E-02 |
| Normal-vs-Age(41-60Yrs) |
5.379900E-04 |
| Normal-vs-Age(61-80Yrs) |
4.414100E-04 |
| Normal-vs-Age(81-100Yrs) |
4.164000E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.558000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.834400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.763400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.344000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.558200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.581000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
3.701400E-01 |
| Normal-vs-Grade 2 |
2.322200E-02 |
| Normal-vs-Grade 3 |
5.87120000394847E-08 |
| Normal-vs-Grade 4 |
6.620300E-04 |
| Grade 1-vs-Grade 2 |
2.768800E-01 |
| Grade 1-vs-Grade 3 |
2.103500E-03 |
| Grade 1-vs-Grade 4 |
2.598300E-02 |
| Grade 2-vs-Grade 3 |
1.922040E-03 |
| Grade 2-vs-Grade 4 |
1.187770E-01 |
| Grade 3-vs-Grade 4 |
3.496800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.235760E-01 |
| Normal-vs-ccB subtype |
1.04999999994693E-06 |
| ccA subtype-vs-ccB subtype |
2.24369999999308E-05 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.049830E-04 |
| Normal-vs-N1 |
9.235800E-02 |
| N0-vs-N1 |
7.578600E-01 |
|
|
